FR3018919B1 - METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF - Google Patents
METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF Download PDFInfo
- Publication number
- FR3018919B1 FR3018919B1 FR1452246A FR1452246A FR3018919B1 FR 3018919 B1 FR3018919 B1 FR 3018919B1 FR 1452246 A FR1452246 A FR 1452246A FR 1452246 A FR1452246 A FR 1452246A FR 3018919 B1 FR3018919 B1 FR 3018919B1
- Authority
- FR
- France
- Prior art keywords
- screening
- applications
- erbb2 inhibitors
- erbb2
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 title 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1452246A FR3018919B1 (en) | 2014-03-18 | 2014-03-18 | METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1452246A FR3018919B1 (en) | 2014-03-18 | 2014-03-18 | METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF |
FR1452246 | 2014-03-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3018919A1 FR3018919A1 (en) | 2015-09-25 |
FR3018919B1 true FR3018919B1 (en) | 2018-03-16 |
Family
ID=51483510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1452246A Expired - Fee Related FR3018919B1 (en) | 2014-03-18 | 2014-03-18 | METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3018919B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200308652A1 (en) * | 2017-10-24 | 2020-10-01 | Universite Paris Descartes | Diagnosis and/or prognosis of her2-dependent cancer using moesin as a biomarker |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120082659A1 (en) * | 2007-10-02 | 2012-04-05 | Hartmut Land | Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations |
WO2011036211A1 (en) * | 2009-09-23 | 2011-03-31 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Polypeptides and nucleic acids for treating erbb2-dependent cancers |
-
2014
- 2014-03-18 FR FR1452246A patent/FR3018919B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR3018919A1 (en) | 2015-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016023105A2 (en) | process and method scheduling | |
FR3020303B1 (en) | METHOD AND INSTALLATION FOR AUTOMATIC PRETENSION OF AN OBJECT. | |
FR3028872B1 (en) | FRACTIONATION METHOD | |
FR3018015B1 (en) | AUTOMATED ACOUSTIC EQUALIZATION METHOD AND SYSTEM | |
FR3026214B1 (en) | METHOD FOR MANAGING ALERTS | |
FR3031641B1 (en) | METHOD OF IDENTIFYING AN ENTITY | |
FR3043811B1 (en) | METHOD OF IDENTIFYING AN ENTITY | |
FR3020157B1 (en) | DIGITAL DETECTION METHOD | |
BR112017007790A2 (en) | horticultural method and apparatus | |
FR3018284B1 (en) | CARD INSTALLATION AND METHOD FOR STARTING SUCH INSTALLATION | |
FR3024974B1 (en) | AEROSTAT AND DEBALLASTAGE METHOD USED IN THIS AEROSTAT | |
FR3019310B1 (en) | METHOD FOR GEO-LOCATION OF THE ENVIRONMENT OF A BEARER | |
FR3032989B1 (en) | FORMING BANK AND METHOD OF PLACING A BANK | |
FR3019967B1 (en) | IMPROVED OSTRECULTURE PROCESS | |
FR3024775B1 (en) | PROCESS FOR IDENTIFYING AND CHARACTERIZING POLYPEPTIDE COMPOUNDS | |
FR3043823B1 (en) | METHOD FOR DECAMOUFLING AN OBJECT | |
FR3019431B1 (en) | PRESENCE TRACKING METHOD | |
FR3020884B1 (en) | METHOD FOR DISPLAYING IMAGES | |
FR3018919B1 (en) | METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF | |
FR3037692B1 (en) | BIOMETRIC IDENTIFICATION METHOD | |
FR3038111B1 (en) | IMAGE SEGMENTATION METHOD | |
FR3019908B1 (en) | METHOD OF PROCESSING SEISMIC IMAGES | |
FR3022168B1 (en) | MACHINING INSTALLATION AND ASSOCIATED METHOD | |
FR3028984B1 (en) | METHOD OF SENDING ELECTRONIC RECOMMENDED MAIL | |
FR3030813B1 (en) | SYSTEM AND METHOD FOR AUTOMATED IDENTIFICATION OF HEMATOPHAGE DIPTERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
ST | Notification of lapse |
Effective date: 20191106 |